Prioritize walking, light weights, and gentle movement
Novo Nordisk first gained FDA approval for Ozempic in December 2017, positioning it as a once-weekly injection for Type 2 diabetes. The 0.5mg and 1mg doses showed impressive blood sugar control, but physicians noticed something else: their patients were losing significant weight
Retatrutide is investigational and not yet FDA-approved
By week 4, many of these patients have moved from significant functional impairment from GI symptoms to largely resolved or substantially reduced symptom burden
Glutathione protects against oxidative stress and neutralises free radicals, while SPF shields the skin from UV damage
M., Waalen, J., Ellervik, C., et al